OSI PHARMACEUTICALS, LLC v. Arch Development Corp. > Summary
Court Case Number IPR2016-01034
Filing Date May 13, 2016
Institution Decision Date Oct 18, 2016
Decision Date Sep 11, 2017
Court Patent Trial and Appeal Board
Status FWD Entered
Appeal2018-1485
Administrative JudgesRobert A. Pollock, Lora M. Green, Michael P. Tierney
Judge Writing the Final DecisionRobert A. Pollock
Claims Challenged in the Petition: 1, 2, 3, 5, 6
Claims Instituted: 1, 2, 3, 5, 6
Claims Invalidated: 1, 2, 3, 5, 6
Petitioner
Patent Owner
Petitioner Attorneys
9OSI Pharmaceuticals
Attorney Name: Matthew A. Chivvis
Morrison & Foerster
OSI Pharmaceuticals
Attorney Name: Matthew I. Kreeger
Morrison & Foerster
OSI Pharmaceuticals
Attorney Name: Emily R. Whelan
Wilmer Cutler Pickering Hale and Dorr
OSI Pharmaceuticals
Attorney Name: Heather M. Petruzzi
Wilmer Cutler Pickering Hale and Dorr
OSI Pharmaceuticals
Attorney Name: David L. Cavanaugh
Wilmer Cutler Pickering Hale and Dorr
OSI Pharmaceuticals
Attorney Name: Margareta K. Sorenson
Wilmer Cutler Pickering Hale and Dorr
OSI Pharmaceuticals
Attorney Name: Amanda L. Major
Wilmer Cutler Pickering Hale and Dorr
OSI Pharmaceuticals
Attorney Name: Amy K. Wigmore
Wilmer Cutler Pickering Hale and Dorr
OSI Pharmaceuticals
Attorney Name: Timothy A. Cook
Wilmer Cutler Pickering Hale and Dorr
Patent Owner Attorneys
8ARCH Development Corporation
Attorney Name: Christopher J. Frerking
ARCH Development Corporation
Attorney Name: Deann F. Smith
Foley Hoag
ARCH Development Corporation
Attorney Name: George C. Summerfield
Stadheim & Grear
ARCH Development Corporation
Attorney Name: Kyle L. Harvey
Stadheim & Grear
ARCH Development Corporation
Attorney Name: Christopher St Peter
Stadheim & Grear
ARCH Development Corporation
Attorney Name: Rolf Otto Stadheim
Stadheim & Grear
ARCH Development Corporation
Attorney Name: Peter A. Sullivan
Foley Hoag
ARCH Development Corporation
Attorney Name: Beata Ichou
Stadheim & Grear
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07838512 | DNA damaging agents in combination with tyrosine kinase inhibitors | Nov 23, 2010 |
